TABLE 8.

The main laboratory indices and safety observation in the treatment of COVID-19.

Detection of laboratory indices	References	Detection of laboratory indices	References	Safety observation	References
White blood cell count (WBC)	Hu et al. (2020), Wang et al., 2020b, Meng et al. (2020)	Lactate dehydrogenase (LDH)	Wang et al., 2020b	Throat swab nuclei cacid detection	Hu et al. (2020), Wang et al., 2020b
Lymphocyte percentage (LYMPH%)	Hu et al. (2020), Wang et al., (2020b), Meng et al. (2020)	Creatine kinase isozyme (CK-MB)	Wang et al., 2020b	Chest computed tomography	Hu et al. (2020), Wang et al., 2020b
Neutrophil percentage (NEUT%)	Hu et al. (2020), Wang et al., (2020b), Meng et al. (2020)	Creatine kinase (CK)	Wang et al., 2020b	Blood biochemistry	Hu et al. (2020), Wang et al., 2020b
Aspartate aminotransferase (AST)	Wang et al., 2020b, Meng et al. (2020)	C-reactive protein (CRP)	Hu et al. (2020), Wang et al., 2020b, Meng et al. (2020)	Electrocardiogram	Hu et al. (2020), Wang et al., 2020b
Erythrocyte sedimentation rate (ESR)	Hu et al. (2020), Wang et al., 2020b	Procalcitonin (PCT)	Hu et al. (2020), Wang et al., 2020b	Observation of adverse reactions	Hu et al. (2020), Wang et al., 2020b
Albumin (ALB)	Hu et al. (2020), Meng et al. (2020)	D-dimer (D-dimer)	Hu et al. (2020), Wang et al., 2020b
Urea (UREA)	Hu et al. (2020), Wang et al., 2020b, Meng et al. (2020)	Alanine aminotransferase (ALT)	Hu et al. (2020), Wang et al., 2020b, Meng et al. (2020)
Creatinine (CREA)	Hu et al. (2020), Wang et al., 2020b, Meng et al. (2020)